ICM
PETS icon

Invenomic Capital Management’s PetMed Express PETS Stock Holding History

Invenomic Capital Management’s Portfolio PETS Stock Details PETS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-97,934
Closed -$325K – 174
2025
Q2 		$325K Sell
97,934
-17,806
-15% -$63.4K 0.02% 147
2025
Q1 		$485K Sell
115,740
-32,682
-22% -$148K 0.02% 171
2024
Q4 		$715K Sell
148,422
-24,231
-14% -$114K 0.03% 158
2024
Q3 		$635K Sell
172,653
-33,332
-16% -$118K 0.03% 142
2024
Q2 		$834K Sell
205,985
-4,244
-2% -$18.1K 0.04% 156
2024
Q1 		$1.01M Sell
210,229
-5,571
-3% -$32.4K 0.05% 139
2023
Q4 		$1.63M Buy
+215,800
New +$1.77M 0.07% 149

Other funds holding PETS

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
OCMI
Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return